Cytokinetics, Incorporated (CYTK)

Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $7.65 billion as of January 16, 2026. Its market cap has increased by 37.83% in one year.

• Market Cap: 7.65B
• Enterprise Value: 8.04B
• 1-Year Change: 37.83%
• Ranking: #1103
• Category: Mid-Cap
• Stock Price: $62.58

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $7.65B, an increase of 1,724.79%. That is a compound annual growth rate of 14.30%.

Market Cap History

Date	Market Cap	% Change
Jan 16, 2026	7.65B	-1.51%
Dec 31, 2025	7.77B	39.94%
Dec 31, 2024	5.55B	-32.19%
Dec 29, 2023	8.19B	88.80%
Dec 30, 2022	4.34B	13.41%
Dec 31, 2021	3.82B	159.95%
Dec 31, 2020	1.47B	134.61%
Dec 31, 2019	626.90M	81.29%
Dec 31, 2018	345.80M	-21.27%
Dec 29, 2017	439.20M	-10.79%
Dec 30, 2016	492.30M	21.17%
Dec 31, 2015	406.30M	38.57%
Dec 31, 2014	293.20M	52.87%
Dec 31, 2013	191.80M	104.04%
Dec 31, 2012	94.00M	35.45%
Dec 30, 2011	69.40M	-49.60%
Dec 31, 2010	137.70M	-22.34%
Dec 31, 2009	177.30M	25.83%
Dec 31, 2008	140.90M	-39.40%
Dec 31, 2007	232.50M	-17.84%
Dec 29, 2006	283.00M	51.01%
Dec 30, 2005	187.40M	-35.49%
Dec 31, 2004	290.50M	-30.72%
Apr 30, 2004	419.30M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	929.76B
Johnson & Johnson	526.82B
AbbVie	378.84B
UnitedHealth Group	299.85B
AstraZeneca	291.69B
Novartis AG	276.38B
Merck & Co.	270.12B
Novo Nordisk	268.23B